Zorro Trades
Small-cap, research analyst, long-term horizon

The Merger Between SafeStitch Medical And TransEnterix: Multi-Bagger Potential

In September of 2013, SafeStitch Medical (SFES) completed its merger with formerly private TransEnterix, a North Carolina-based company that develops minimally invasive surgical devices. SafeStitch Medical develops medical devices that are focused towards treating obesity, hernias, and gastro-esophageal reflux disease (GERD), with an emphasis on minimal invasiveness. The synergies between TransEnterix and SafeStitch are abundant, and the newly formed company that raised $30.2 million in a private equity offering last month has ample room to develop and market its two potential blockbuster products, the Spider Surgical System and the Surgi-Bot. The technology behind the Spider System that TransEnterix is bringing to the market is disruptive, and will surely give Intuitive Surgical's (NASDAQ:ISRG) da Vinci System a run for...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
FREESA PRO MEMBERS
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details